These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 30036611)
1. Abdominal obesity phenotypes and incident diabetes over 12 years of follow-up: The Tehran Lipid and glucose study. Salehinia F; Abdi H; Hadaegh F; Serahati S; Valizadeh M; Azizi F; Hosseinpanah F Diabetes Res Clin Pract; 2018 Oct; 144():17-24. PubMed ID: 30036611 [TBL] [Abstract][Full Text] [Related]
2. Risk of all-cause mortality in abdominal obesity phenotypes: Tehran Lipid and Glucose Study. Doustmohamadian S; Serahati S; Barzin M; Keihani S; Azizi F; Hosseinpanah F Nutr Metab Cardiovasc Dis; 2017 Mar; 27(3):241-248. PubMed ID: 28139376 [TBL] [Abstract][Full Text] [Related]
3. Abdominal obesity phenotypes and risk of cardiovascular disease in a decade of follow-up: the Tehran Lipid and Glucose Study. Keihani S; Hosseinpanah F; Barzin M; Serahati S; Doustmohamadian S; Azizi F Atherosclerosis; 2015 Feb; 238(2):256-63. PubMed ID: 25540856 [TBL] [Abstract][Full Text] [Related]
4. Abdominal obesity phenotypes and risk of kidney function decline: Tehran Lipid and Glucose Study. Shahali A; Tasdighi E; Barzin M; Mahdavi M; Valizadeh M; Niroomand M; Azizi F; Hosseinpanah F Obes Res Clin Pract; 2020; 14(2):168-175. PubMed ID: 32307280 [TBL] [Abstract][Full Text] [Related]
5. Abdominal Obesity Phenotypes and Incidence of Thyroid Autoimmunity: A 9-Year Follow-up. Amouzegar A; Kazemian E; Abdi H; Gharibzadeh S; Tohidi M; Azizi F Endocr Res; 2020 Aug; 45(3):202-209. PubMed ID: 32266835 [TBL] [Abstract][Full Text] [Related]
6. All-cause mortality risk of metabolically healthy abdominal obese individuals: the EPIC-MORGEN study. van der A DL; Nooyens AC; van Duijnhoven FJ; Verschuren MM; Boer JM Obesity (Silver Spring); 2014 Feb; 22(2):557-64. PubMed ID: 23595997 [TBL] [Abstract][Full Text] [Related]
7. Cardiovascular risk in different obesity phenotypes over a decade follow-up: Tehran Lipid and Glucose Study. Mirzaei B; Abdi H; Serahati S; Barzin M; Niroomand M; Azizi F; Hosseinpanah F Atherosclerosis; 2017 Mar; 258():65-71. PubMed ID: 28213199 [TBL] [Abstract][Full Text] [Related]
8. Natural course of metabolically healthy abdominal obese adults after 10 years of follow-up: the Tehran Lipid and Glucose Study. Eshtiaghi R; Keihani S; Hosseinpanah F; Barzin M; Azizi F Int J Obes (Lond); 2015 Mar; 39(3):514-9. PubMed ID: 25287753 [TBL] [Abstract][Full Text] [Related]
9. Joint associations of metabolically healthy abdominal obesity and non-alcoholic fatty liver disease with prediabetes and diabetes in Chinese adults. Zhang J; Xu Q; Lai F; Chen N; Lin M; Liu Y; Zhang W; Liu C; Wang S; Li Z BMJ Open Diabetes Res Care; 2021 Aug; 9(1):. PubMed ID: 34433546 [TBL] [Abstract][Full Text] [Related]
10. Predictors of incident obesity phenotype in nonobese healthy adults. Eftekharzadeh A; Asghari G; Serahati S; Hosseinpanah F; Azizi A; Barzin M; Mirmiran P; Azizi F Eur J Clin Invest; 2017 May; 47(5):357-365. PubMed ID: 28294315 [TBL] [Abstract][Full Text] [Related]
11. Association of endotoxaemia with serum free fatty acids in metabolically healthy and unhealthy abdominally obese individuals: a case-control study in northwest of Iran. Saghafi-Asl M; Amiri P; Naghizadeh M; Ghavami SM; Karamzad N BMJ Open; 2017 May; 7(5):e015910. PubMed ID: 28487462 [TBL] [Abstract][Full Text] [Related]
12. Overweight and Obesity: Findings from 20 Years of the Tehran Lipid and Glucose Study. Barzin M; Valizadeh M; Serahati S; Mahdavi M; Azizi F; Hosseinpanah F Int J Endocrinol Metab; 2018 Oct; 16(4 Suppl):e84778. PubMed ID: 30584443 [TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor signaling and serum levels of interferon β and lipopolysaccharide binding protein are related to abdominal obesity: a case-control study between metabolically healthy and metabolically unhealthy obese individuals. Naghizadeh M; Baradaran B; Saghafi-Asl M; Amiri P; Shanehbandi D; Karamzad N; Mohamed-Khosroshahi L Nutr Res; 2018 Jul; 55():11-20. PubMed ID: 29914624 [TBL] [Abstract][Full Text] [Related]
14. Is incident type 2 diabetes associated with cumulative excess weight and abdominal adiposity? Tehran Lipid and Glucose Study. Zameni F; Bakhtiyari M; Mansournia MA; Ramezankhani A; Azizi F; Hadaegh F Diabetes Res Clin Pract; 2018 Feb; 136():134-142. PubMed ID: 29229382 [TBL] [Abstract][Full Text] [Related]
15. Sex specific impact of different obesity phenotypes on the risk of incident hypertension: Tehran lipid and glucose study. Kabootari M; Akbarpour S; Azizi F; Hadaegh F Nutr Metab (Lond); 2019; 16():16. PubMed ID: 30858870 [TBL] [Abstract][Full Text] [Related]
16. Association between obesity phenotypes in adolescents and adult metabolic syndrome: Tehran Lipid and Glucose Study. Asghari G; Hosseinpanah F; Serahati S; Haghi S; Azizi F Br J Nutr; 2019 Dec; 122(11):1255-1261. PubMed ID: 31506131 [TBL] [Abstract][Full Text] [Related]
17. Association of obesity phenotypes in adolescents and incidence of early adulthood type 2 diabetes mellitus: Tehran lipid and glucose study. Yaghoubpour K; Tasdighi E; Abdi H; Barzin M; Mahdavi M; Valizadeh M; Azizi F; Hosseinpanah F Pediatr Diabetes; 2021 Nov; 22(7):937-945. PubMed ID: 34173705 [TBL] [Abstract][Full Text] [Related]
18. Emotional states of different obesity phenotypes: a sex-specific study in a west-Asian population. Mehrabi F; Amiri P; Cheraghi L; Kheradmand A; Hosseinpanah F; Azizi F BMC Psychiatry; 2021 Mar; 21(1):124. PubMed ID: 33663426 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of overweight/obesity, abdominal obesity and metabolic syndrome and atypical cardiometabolic phenotypes in the adult Romanian population: PREDATORR study. Popa S; Moţa M; Popa A; Moţa E; Serafinceanu C; Guja C; Catrinoiu D; Hâncu N; Lichiardopol R; Bala C; Popa A; Roman G; Radulian G; Timar R; Mihai B J Endocrinol Invest; 2016 Sep; 39(9):1045-53. PubMed ID: 27126310 [TBL] [Abstract][Full Text] [Related]
20. Metabolically healthy general and abdominal obesity are associated with increased risk of hypertension. Zhao Y; Qin P; Sun H; Liu Y; Liu D; Zhou Q; Guo C; Li Q; Tian G; Wu X; Hu D; Sun X; Zhang M Br J Nutr; 2020 Mar; 123(5):583-591. PubMed ID: 31791429 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]